Login

Interview of Alexandre Fraichard, CEO, Genoway 00:00:00

Share On Facebook Share On Twitter

Interview of Alexandre Fraichard, CEO, Genoway

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Apollo Global Management: Insights from the Co-Head of European Credit and Former National Schools Rugby Player | Leslie Mapondera - Partner of Apollo Global Management, LLC
00:10:00
Constraints before making contact: you will have a much higher chance of success if your outreach is targeted|Ali Moiz,Founder and CEO, Stonks
00:10:00
Your Investment Partner for the Long Run|Bruce Richards,CEO,Marathon Asset Management
00:10:00
Intellectual Property Battles: Anglo-American Power Shift in Defense Technology|Katherine C. Epstein
00:10:00
Power of Disrupting Financial Systems|Kwame Anku,Chairman & CEO,Black Star Fund
00:10:00
Focus Minerals CEO Campbell Baird Discusses Gold Reserves Expansion and Strategic Advantages at Symposium
00:10:00
Drax Group CEO Will Gardiner responds to inquiries regarding Drax's Canadian biomass operations in a video statement and provides additional details in the accompanying article.
00:10:00
Hoskins, Managing Director of Graphics Mining: Developing Tanzania's Cello Graphite Project with Robust Economics and Market-Leading Strategy
00:10:00
The Impact of Comprehensive Wealth Management | David John Marotta, President , Marotta Wealth Management Inc.
00:10:00
Private Equity in Sri Lanka: Opportunities for Growth and Investment Insights from Zephyr Management's Thomas Barry
00:10:00
Tony Fernandes Dismisses Retirement Rumors, Forecasts Tourism-Led Recovery for AirAsia | Tony Fernandes, CEO, AirAsia Bhd.
00:10:00
Where the world is headed versus where it currently exists|Peter C. Lewis,CHAIRMAN,Wharton Equity Partners

© 2017 - Neuhu+